Czech National Bank Purchases 21,173 Shares of Oracle Corporation $ORCL

Czech National Bank lifted its position in shares of Oracle Corporation (NYSE:ORCL) by 4.6% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 482,993 shares of the enterprise software provider’s stock after acquiring an additional 21,173 shares during the quarter. Czech National Bank’s holdings in Oracle were worth $70,783,000 at the end of the most recent reporting period.

Several other hedge funds have also added to or reduced their stakes in the company. Norges Bank bought a new position in shares of Oracle in the 4th quarter valued at about $4,336,031,000. Capital Research Global Investors grew its position in shares of Oracle by 29.3% during the 4th quarter. Capital Research Global Investors now owns 30,137,126 shares of the enterprise software provider’s stock worth $5,874,070,000 after buying an additional 6,826,299 shares during the period. Vanguard Group Inc. raised its stake in shares of Oracle by 3.5% during the fourth quarter. Vanguard Group Inc. now owns 174,802,084 shares of the enterprise software provider’s stock worth $34,070,674,000 after buying an additional 5,841,584 shares during the last quarter. Cardano Risk Management B.V. lifted its holdings in Oracle by 882.3% in the fourth quarter. Cardano Risk Management B.V. now owns 4,991,010 shares of the enterprise software provider’s stock valued at $972,798,000 after buying an additional 4,482,934 shares during the period. Finally, FIL Ltd lifted its holdings in Oracle by 1,605.7% in the fourth quarter. FIL Ltd now owns 3,976,441 shares of the enterprise software provider’s stock valued at $775,048,000 after buying an additional 3,743,314 shares during the period. Institutional investors own 42.44% of the company’s stock.

Oracle Trading Down 0.7%

ORCL opened at $143.43 on Friday. The stock has a market capitalization of $413.14 billion, a P/E ratio of 24.60, a P/E/G ratio of 0.91 and a beta of 1.72. The company has a current ratio of 1.12, a quick ratio of 1.12 and a debt-to-equity ratio of 3.21. Oracle Corporation has a 12 month low of $114.50 and a 12 month high of $345.72. The firm’s fifty day simple moving average is $159.80 and its 200 day simple moving average is $162.72.

Oracle (NYSE:ORCL) last released its earnings results on Wednesday, June 10th. The enterprise software provider reported $2.11 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.96 by $0.15. Oracle had a return on equity of 58.62% and a net margin of 25.37%.The firm had revenue of $19.18 billion during the quarter, compared to analysts’ expectations of $19.10 billion. During the same quarter in the prior year, the company earned $1.70 EPS. The company’s revenue was up 20.6% on a year-over-year basis. Oracle has set its Q1 2027 guidance at 1.720-1.760 EPS and its FY 2027 guidance at 8.050-8.050 EPS. As a group, research analysts anticipate that Oracle Corporation will post 6.47 EPS for the current fiscal year.

Oracle Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, July 24th. Investors of record on Friday, July 10th were issued a dividend of $0.50 per share. The ex-dividend date was Friday, July 10th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.4%. Oracle’s dividend payout ratio (DPR) is presently 34.31%.

Insider Transactions at Oracle

In related news, Vice Chairman Jeffrey Henley sold 400,000 shares of Oracle stock in a transaction that occurred on Wednesday, June 24th. The stock was sold at an average price of $159.16, for a total value of $63,664,000.00. Following the sale, the insider owned 400,000 shares of the company’s stock, valued at approximately $63,664,000. This trade represents a 50.00% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 40.90% of the company’s stock.

Analysts Set New Price Targets

Several research firms have recently issued reports on ORCL. BMO Capital Markets raised their price target on Oracle from $200.00 to $220.00 and gave the stock an “outperform” rating in a research report on Thursday, June 11th. Wolfe Research reissued an “outperform” rating and set a $225.00 price objective on shares of Oracle in a research note on Thursday, June 11th. Wedbush decreased their price objective on shares of Oracle from $275.00 to $240.00 and set an “outperform” rating for the company in a report on Thursday, June 11th. UBS Group cut their target price on shares of Oracle from $285.00 to $245.00 and set a “buy” rating on the stock in a report on Thursday. Finally, CLSA started coverage on shares of Oracle in a research report on Monday, July 20th. They set a “hold” rating and a $145.00 price target on the stock. Two research analysts have rated the stock with a Strong Buy rating, twenty-eight have issued a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $263.97.

Oracle News Summary

Here are the key news stories impacting Oracle this week:

• Positive Sentiment: Oracle’s cloud ERP and database businesses remain important growth drivers, supporting the company’s long-term expansion outlook. Oracle: Cloud ERP And Oracle Database Software Driving Growth
• Positive Sentiment: Oracle won a joint electronic health-record rollout with Ontario hospitals Baycrest and Sunnybrook, adding to evidence of demand for its healthcare technology. Oracle Lands Joint Ontario Hospital EHR Rollout
• Positive Sentiment: Wall Street analysts remain broadly bullish despite Oracle’s weak performance over the past year, while recent quarterly results showed revenue growth of 20.6% and earnings above consensus estimates. Do Wall Street Analysts Like Oracle Stock?
• Neutral Sentiment: Oracle’s quarterly dividend payment highlights its shareholder-return profile, but the $0.50-per-share payout is unlikely to materially change the near-term trading outlook. Larry Ellison Dividend Article
• Negative Sentiment: Concerns that debt-funded AI data-center investment could push Oracle’s credit rating toward junk status are the clearest fundamental overhang. Higher borrowing costs and leverage could reduce the value of future AI-related cash flows. Oracle AI Expansion and Credit Rating Concerns
• Negative Sentiment: Michael Burry has re-entered put positions on ORCL after previously closing an Oracle short, drawing attention to renewed bearish views on valuation, debt and execution risk. Michael Burry Re-enters Oracle Put Positions
• Negative Sentiment: A lower close across the major U.S. indexes amid uncertainty over the Strait of Hormuz and upcoming jobs data is adding to risk-off pressure on technology stocks. U.S. Markets End Lower Amid Hormuz Uncertainty

Oracle Company Profile

Oracle Corporation is a multinational technology company that develops and sells database software, cloud engineered systems, enterprise software applications and related services. The company is widely known for its flagship Oracle Database and a portfolio of enterprise-grade software products that support data management, application development, analytics and middleware. Over recent years Oracle has expanded its focus to include cloud infrastructure and cloud applications, positioning itself as a provider of both platform and software-as-a-service solutions for large organizations.

Oracle’s product and service offerings include Oracle Database and the Autonomous Database, Oracle Cloud Infrastructure (OCI), enterprise resource planning (ERP), human capital management (HCM) and supply chain management (SCM) cloud applications (often grouped under Oracle Fusion Cloud Applications), middleware such as WebLogic, and developer technologies including Java and MySQL.